Prospective study on the cytological aspects of the nasal respiratory epithelium in premenopausal women taking 30 mcg ethinylestradiol and 3 mg drospirenone oral contraceptive

Contraception

Volumn 77, Issue 5, 2008, Pages 344-349

  Caruso, Salvatore ^a   Serra, Agostino ^a   Grillo, Calogero ^a   Agnello, Carmela ^a   Di Mari, Lucia ^a   Cianci, Antonio ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

Drospirenone; Ethinylestradiol; Maturation index; Menstrual cycle; Nasal epithelium; Oral contraceptives

Indexed keywords

DROSPIRENONE PLUS ETHINYLESTRADIOL; PROGESTERONE;

ADULT; ARTICLE; BLEEDING; CELL MATURATION; CLINICAL ARTICLE; CYTOLOGY; EVALUATION RESEARCH; FEMALE; FOLLICULAR PHASE; HUMAN; HUMAN TISSUE; LUTEAL PHASE; MENSTRUAL CYCLE; NOSE MUCOSA; ORAL CONTRACEPTION; PREMENOPAUSE; PROGESTERONE BLOOD LEVEL; PROSPECTIVE STUDY; RESPIRATORY EPITHELIUM; SPOTTING;

ADULT; ANDROSTENES; CONTRACEPTIVES, ORAL, COMBINED; CONTRACEPTIVES, ORAL, SYNTHETIC; ETHINYL ESTRADIOL; FEMALE; HUMANS; NASAL MUCOSA; PREMENOPAUSE; PROSPECTIVE STUDIES;

EID: 41549149016     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2007.12.010     Document Type: Article

References (34)

1. Caruso S., Roccasalva L., Sapienza G., Zappalà M., Nuciforo G., and Biondi S. Laryngeal cytological aspects in women with surgically induced menopause who were treated with transdermal estrogen replacement therapy. Fertil Steril 74 (2000) 1073-1079
2. Caruso S., Roccasalva L., Di Fazio E., et al. Cytologic aspects of the nasal respiratory epithelium in postmenopausal women treated with hormone therapy. Fertil Steril 79 (2003) 543-549
3. Serra A., Maiolino L., Farina M., et al. Cytologic aspects of the nasal respiratory epithelium throughout the menstrual cycle. Ann Otol Rhinol Larygol 113 (2004) 667-671
4. Caruso S., Serra A., Maiolino L., et al. Cytological aspects of the nasal respiratory epithelium in reproductive-age women taking oral contraceptives. Eur J Contracept Reprod Health Care 11 (2006) 250-257
5. Finger T.E., and Silver W.L. Neurobiology of taste and smell (1991), Krieger Publishing Co, Malabar (Fla)
6. Doty R.L. Studies of human olfaction from the University of Pennsylvania Smell and Taste Center. Chem Senses 22 (1997) 565-586
7. Serra A., Maiolino L., Agnello C., Messina A., and Caruso S. Auditory brainstem response throughout the menstrual cycle. Ann Otol Rhinol Laryngol 112 (2003) 549-553
8. Caruso S., Cianci A., Grasso D., et al. Auditory brainstem response in postmenopausal women treated with hormone replacement therapy: a pilot study. Menopause 7 (2000) 178-183
9. Caruso S., Maiolino L., Agnello C., Garozzo A., Di Mari L., and Serra A. Effects of patch or gel estrogen therapies on auditory brainstem response in surgically postmenopausal women: a prospective, randomized study. Fertil Steril 79 (2003) 556-561
10. Grillo C., La Mantia I., Triolo C., Scollo A., Intelisano G., and Caruso S. Rhinomanometric and olfactometric variations throughout the menstrual cycle. Ann Otol Rhinol Laryngol 110 (2001) 785-789
11. Caruso S., Grillo C., Agnello C., Maiolino L., Intelisano G., and Serra A. A prospective study evidencing rhinomanometric and olfactometric outcomes in women taking oral contraceptives. Hum Reprod 16 (2001) 2288-2294
12. Caruso S., Grillo C., Agnello C., di Mari L., Farina M., and Serra A. Olfactometric and rhinomanometric outcomes in postmenopausal women treated with hormone therapy: a prospective study. Hum Reprod 19 (2004) 2859-2864
13. Brittebo E.B. Localization of oestradiol in the rat nasal mucosa. Acta Pharmacol Toxicol 57 (1985) 285-290
14. Helmi A.M., El Ghazzawi I.F., Mandour M.A., and Shehata M.A. The effect of oestrogen on the nasal respiratory mucosa. An experimental histopathological and histochemical study. J Laryngol Otol 89 (1975) 1229-1241
15. Zhao X., Dong Z., and Yang Z. An experimental observation on the influence of the different levels of estradiol on the nasal mucosa. Zhonghua Er Bi Yan Hou Ke Za Zhi 29 (1994) 98-100
16. Nakashima T., Kimmelman C.P., and Snow J.B. Structure of human fetal and adult olfactory neuroepithelium. Arch Otolaryngol 110 (1984) 641-646
17. Mair R.G., Bouffard J.A., Engen T., and Morton T.H. Olfactory sensitivity during the menstrual cycle. Sens Processes 2 (1978) 90-98
18. Poran N.S. Cyclic attractivity of human female odors. In: Apfelbach R., Muller-Schwarze D., Reutter K., and Weiler E. (Eds). Chemical signals in vertebrates VII (1995), Elsevier Science Ltd, Oxford, England 561-569
19. Russell M.J., Switz G.M., and Thompson K. Olfactory influence on the human menstrual cycle. Pharmacol Biochem Behav 13 (1980) 737-738
20. Pause B., Sojka B., Krauel K., Fehm-Wolfsdorf G., and Ferstl R. Olfactory information processing during the course of the menstrual cycle. Biol Psychol 44 (1996) 31-54
21. Wedekind C., Seebeck T., Bettens F., and Paepke A.J. MHC-dependent mate preferences in human. Proc R Soc Lond B Biol Sci 260 (1995) 245-249
22. Serfaty D., Wildemeersch D., Verougstraete A., and Creatsas G. European Society of Contraception oral contraceptives survey update: birth control methods in Europe of the 12Q. Int J Fertil 40 (1995) 73-79
23. Cedars M.I. Triphasic oral contraceptives: review and comparison of various regimens. Fertil Steril 77 (2002) 1-14
24. Oelkers W., Foidart J.M., Dombrovicz N., et al. Effects of a new oral mcg contraceptive containing an antimineralocorticoid progestogen, drospirenone, on the renin-aldosterone system, body weight, blood pressure, glucose tolerance, and lipid metabolism. J Clin Endocrinol Metab 80 (1995) 1816-1821
25. Krattenmacher R. Drospirenone: pharmacology and pharmacokinetics of a unique progestogen. Contraception 62 (2000) 29-38
26. Thorneycroft I.H. Yasmin: the reason why. Eur J Contracept Reprod Health Care 7 (2002) 13-18
27. Dinger J.C., Heinemann L.A.J., and Kühl-Habich D. The safety of a drospirenone-containing oral contraceptive: final results from the European Active Surveillance Study on Oral Contraceptives based on 142,475 women-years of observation. Contraception 75 (2007) 344-354
28. Apter D., Dorsos A., Baumgartner W., et al. Effect of an oral contraceptive containing drospirenone and ethinylestradiol on general well-being and fluid-related symptoms. Eur J Contracept Reprod Health Care 8 (2003) 37-51
29. van der Laak J.A., Schijf C.P., Kerstens H.M., Heijnen-Wijnen T.H., de Wilde P.C., and Hanselaar G.J. Development and validation of a computerized cytomorphometric method to assess the maturation of vaginal epithelial cells. Cytometry 35 (1999) 196-202
30. Navarrete-Palacios E., Hudson R., Reyes-Guerrero G., and Guevara-Guzmán R. Correlation between cytological characteristics of the nasal epithelial and the menstrual cycle. Arch Otolaryngol Head Neck Surg 129 (2003) 460-463
31. van der Laak J.A., de Bie L.M.T., de Leeuw H., de Wilde P.C., and Hanselaar G.J. The effect of Replens on vaginal cytology in the treatment of postmenopausal atrophy: cytomorphology versus computerised cytometry. J Clin Pathol 55 (2002) 446-451
32. Toppozada H. The human nasal mucosa in the menopause (a histochemical and electron microscopic study). J Laryngol Otol 102 (1988) 314-318
33. Caruso S., Agnello C., Intelisano G., et al. Prospective study on sexual behavior of women using 30 mcg ethinylestradiol and 3 mg drospirenone oral contraceptive. Contraception 72 (2005) 19-23
34. Caruso S., Agnello C., Intelisano G., Farina M., Di Mari L., and Cianci A. Sexual behavior of women taking low-dose oral contraceptive containing 15 mcg ethinylestradiol/60 mg gestodene. Contraception 69 (2004) 237-240